NCT01471743

Brief Summary

Surgical patients are high risk for post operative infections. These post operative infections contribute to increased length of hospital stay, hospital costs and delay overall recovery time thus decreasing the quality of life. Studies have reported post operative complications ranging from 37% to 74%.1 The most costly complications include infectious complications after major Gastrointestinal (GI) surgery including wound infections, abdominal abscess, pneumonia, sepsis and anastomic leaks.2 Several studies have been conducted that show a significant reduction in infectious complications and average length of stay when treated with immunonutrition supplements.2-3 A review of similarly designed studies in a different patient population indicate that post-operative infections can be reduced by an average of 71% with immunonutrition. This study seeks to investigate the effect of Impact Advanced Recovery ® in improving surgical outcomes in patients receiving major gastrointestinal surgeries compared to a standard supplement at James A. Haley Veterans' Hospital. Providing Impact Advanced Recovery ® may decrease post-operative infectious complications, length of stay, and recovery time. Hypothesis

  1. 1.In patients receiving elective gastrointestinal surgery (esophageal, gastric, pancreatic or colon resections) there will be a significant decrease of at least 60% in post-operative infections as listed below for patients who consume 15 servings of Impact Advanced Recovery® pre-operatively compared to patients who consume 15 servings of a standard supplement.
  2. 2.In patients receiving elective gastrointestinal surgery (esophageal, gastric, pancreatic or colon resections) there will be a significant decrease in hospital and NPO days for patients who consume 15 servings of Impact Advanced Recovery ® pre-operatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

November 9, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 16, 2011

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

February 23, 2016

Status Verified

February 1, 2016

Enrollment Period

4.3 years

First QC Date

November 9, 2011

Last Update Submit

February 22, 2016

Conditions

Keywords

nutritionsurgeryimmune

Outcome Measures

Primary Outcomes (1)

  • Number of participants with post-op Infections

    Determine the effectiveness of pre-operative supplementation with Impact Advanced Recovery ® on reducing the risk of developing complications during the 30 day post-operative period with decreased length of hospital stay, and time to resume an oral diet.

    within 30 days post-operatively

Study Arms (2)

Impact Advance Recovery (R)

EXPERIMENTAL

3 supplements per day for 5 days pre-operatively

Dietary Supplement: Impact Advance Recovery (R)

Standard Supplement

ACTIVE COMPARATOR

3 supplement per day for 5 days pre-operatively

Dietary Supplement: Ensure Plus (R)

Interventions

Impact Advance Recovery (R)DIETARY_SUPPLEMENT
Impact Advance Recovery (R)
Ensure Plus (R)DIETARY_SUPPLEMENT
Standard Supplement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically documented neoplasm of the gastrointestinal tract.
  • Planned major elective surgery including esophageal, gastric, pancreatic or colon resections.

You may not qualify if:

  • Critically ill patients defined as any patient admitted to the intensive care unit (ICU) prior to elective surgery.
  • Current use of steroids or other immunosuppressive medications.
  • History of hospitalization for pulmonary, cardiac or renal disease in the 6 months prior to elective surgery.
  • Patients who exhibit signs and symptoms of infection or sepsis including: elevated WBC above 10,000 cells/ml; temperature \> 37.7 C

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James A. Haley VA Hospital

Tampa, Florida, 33612, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Clinical Nutrition

Study Record Dates

First Submitted

November 9, 2011

First Posted

November 16, 2011

Study Start

November 1, 2011

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

February 23, 2016

Record last verified: 2016-02

Locations